News

Understanding CrowdStrike Holdings' Recent Options Activity

Understanding CrowdStrike Holdings' Recent Options Activity

An In-Depth Look at CrowdStrike Holdings Options Activity

Recently, the financial landscape has highlighted an intriguing bearish trend regarding CrowdStrike Holdings (NASDAQ: CRWD). Our analysis indicates that there have been 65 unusual options trades surrounding this prominent cybersecurity firm. A deeper dive into this activity reveals that only 38% of traders held optimistic views, while a notable 52% leaned towards a bearish outlook.

Within the trades detected, 22 were puts amounting to a substantial $1,517,972, contrasting with 43 call trades valued at $2,158,717. These figures encapsulate the prevalent market sentiment around CrowdStrike, indicating a cautious stance among many investors.

Projected Price Movements

The options data suggests that significant market players, often referred to as "whales", are focusing on a price target ranging between $75.0 and $580.0 for CrowdStrike Holdings over the past few months. This wide range illustrates the market's uncertainty yet confidence in the company's future performance.

Volume and Open Interest Insights

Currently, options for CrowdStrike reflect an average open interest of 417.98, culminating in a total trading volume of 3,776.00. This level of activity, particularly in high-value trades, signals robust engagement amongst traders. The analysis further showcases the fluctuations of both call and put options, specifically tracking trades executed within a price corridor spanning from $75.0 to $580.0, over the last 30 days.

Analysis of Recent Options Trading

Examining the last month's trading activity reveals significant options trades based on the following data:

Highlighted Options Trades:

Key options transactions within CrowdStrike have illustrated various sentiments:

Symbol: CRWD

PUT/CALL: PUT

Trade Type: SWEEP

Sentiment: BULLISH

Expiration Date: February 28, 2025

Average Ask Price: $17.85

Average Bid Price: $17.00

Trade Price: $17.27

Strike Price: $400.00

Total Trade Value: $344.6K

Open Interest: 888

Volume: 591

In contrast, there are also several neutral and bearish trades recorded, underscoring the varied perspectives on CRWD's market direction.

Overview of CrowdStrike Holdings

Founded in 2011, CrowdStrike has emerged as a premier cloud-based cybersecurity company. It specializes in cutting-edge security solutions relevant to the endpoint, cloud workload, identity management, and security operations sectors. At the heart of its offerings lies the Falcon platform, designed to provide comprehensive visibility across an enterprise's digital landscape, empowering companies to swiftly detect and neutralize potential threats.

As we analyze the options surrounding CrowdStrike, it's essential to turn our attention toward the company's current performance. As of the latest trading session:

Current Market Snapshot for CrowdStrike Holdings

  • Current trading volume stands at 2,939,790 shares, with CRWD's price positioned at $393.38, reflecting a decrease of -3.27%.
  • Relative Strength Index (RSI) indicators suggest that the stock might be nearing oversold conditions.
  • A significant earnings announcement is anticipated shortly, potentially impacting market perceptions.

Expert Analyst Ratings for CrowdStrike Holdings

The last month has seen substantial input from analysts, with an average price target set at $468.2. Remarks have varied, with specific adjustments made:

  • An analyst from Baird has lowered the rating to Neutral, revised with a target of $430.
  • Conversely, Mizuho has retained an Outperform rating with a target of $450.
  • Keybanc keeps an Overweight rating, suggesting a price target of $480.
  • Barclays also maintains an Overweight assessment, with a target set at $506.
  • Lastly, Stifel holds a Buy rating, supporting a price target of $475.

Investing in options can carry inherent risks, paired with potential high rewards. It is vital for traders to remain continually informed, adapting their strategies while monitoring various market indicators. For those keen on tracking the latest options trades for CrowdStrike Holdings, real-time alerts are advisable.

Frequently Asked Questions

What has driven the recent options activity for CrowdStrike?

Recent bearish trends have prompted heightened options trading interest, with notable input from traders indicating varying sentiments about the stock's direction.

What are the projected price targets for CrowdStrike Holdings?

Officials have indicated a potential price range between $75.0 to $580.0 based on current market movements and options activity.

How is CrowdStrike Holdings performing in the market now?

Currently, the trading volume sits at nearly 3 million, with a price approximately $393.38, showing some downward movement recently.

What do analysts think about CrowdStrike's future?

Expert analysts remain optimistic, setting a collective average price target around $468.2, with varied affirmations of performance predictions.

How can I stay updated on CrowdStrike options trades?

Investors are encouraged to utilize real-time alerts for the latest options trading details to make informed decisions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Encouraged to Join Ibotta Class Action at Gross Law Firm

Updated Category News Views 130

Investors Urged to Take Action in Ibotta Class Action Lawsuit If you have invested in Ibotta, Inc. (NYSE: IBTA), it may be time to pay attention. Shareholders are being encouraged to take part in a class action lawsuit that seeks to address the alleged wrongdoings associated with the company's public offering. This initiative is spearheaded by The Gross Law Firm, which...

Continue Reading
TOMI Environmental Solutions Welcomes Harold W. Paul to Board

Updated Category News Views 197

Strategic Board Appointment at TOMI Environmental Solutions TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a key player in the realm of disinfection and decontamination technologies, recently announced an important addition to its Board of Directors. Harold W. Paul has been appointed to this role, a move that is expected to have a significant positive impact on the...

Continue Reading
MaxCyte's Innovative Collaboration with Moonlight Bio on T Cell Therapies

Updated Category News Views 170

MaxCyte Forms Strategic Alliance with Moonlight Bio MaxCyte, Inc. (Nasdaq: MXCT), a pioneering cell-engineering organization, has recently announced a significant collaborative effort with Moonlight Bio, a Seattle-based company focused on pioneering preclinical-stage T cell therapies. This partnership will leverage MaxCyte’s advanced technologies to propel the...

Continue Reading
ZenaTech Showcases Drone Innovations and Future Strategy

Updated Category News Views 114

Revolutionizing Drone Services and Defense Innovations VANCOUVER, British Columbia — ZenaTech, Inc. (NASDAQ: ZENA) (BMV: ZENA) (FSE: 49Q) stands at the forefront of technological solutions, focusing on the exciting realm of Drone as a Service (DaaS) as well as commercial drone developments catering to various industries. The company recently announced its participation...

Continue Reading
Lavu's CEO to Share Insights on AI and Payment Innovations

Updated Category News Views 126

Lavu's CEO to Share Insights on AI and Payment Innovations Lavu, a trailblazer in restaurant AI platforms, is gearing up for an enlightening presentation featuring its CEO, Saleem S. Khatri. He will be a keynote speaker at an upcoming event focusing on the intersection of fintech, AI, and payment systems. A Discussion on Restaurant Operations and Payments The session,...

Continue Reading